---
title: "Kuros Biosciences Hits Record Sales and First Profit as MagnetOs Fuels Global Expansion"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/278501704.md"
description: "Kuros Biosciences Hits Record Sales and First Profit as MagnetOs Fuels Global Expansion"
datetime: "2026-03-10T06:34:35.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/278501704.md)
  - [en](https://longbridge.com/en/news/278501704.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/278501704.md)
---

# Kuros Biosciences Hits Record Sales and First Profit as MagnetOs Fuels Global Expansion

Kuros Biosciences Hits Record Sales and First Profit as MagnetOs Fuels Global Expansion

### Related Stocks

- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [CTKB.US](https://longbridge.com/en/quote/CTKB.US.md)
- [MBX.US](https://longbridge.com/en/quote/MBX.US.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [XBIO.US](https://longbridge.com/en/quote/XBIO.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [KROS.US](https://longbridge.com/en/quote/KROS.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)

## Related News & Research

- [LifeSci Capital Remains a Buy on MBX Biosciences, Inc. (MBX)](https://longbridge.com/en/news/286648301.md)
- [BeOne Medicines Sets the Pace in Oncology at ASCO and EHA 2026 with 60+ Abstracts | ONC Stock News](https://longbridge.com/en/news/287198763.md)
- [14:05 ETLupin Receives Tentative Approval from U.S. FDA for Revefenacin Inhalation Solution](https://longbridge.com/en/news/286805922.md)
- [BUZZ-Street View: Regeneron's melanoma trial setback raises bigger-picture questions](https://longbridge.com/en/news/286769076.md)
- [BeOne Medicines: Recent FDA Approval Rewrites One-Drug Narrative](https://longbridge.com/en/news/287245995.md)